IL146798A0 - A structured peptide scaffold for displaying turn libraries on phage - Google Patents

A structured peptide scaffold for displaying turn libraries on phage

Info

Publication number
IL146798A0
IL146798A0 IL14679800A IL14679800A IL146798A0 IL 146798 A0 IL146798 A0 IL 146798A0 IL 14679800 A IL14679800 A IL 14679800A IL 14679800 A IL14679800 A IL 14679800A IL 146798 A0 IL146798 A0 IL 146798A0
Authority
IL
Israel
Prior art keywords
peptides
phage
directed
peptide scaffold
libraries
Prior art date
Application number
IL14679800A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL146798A0 publication Critical patent/IL146798A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14679800A 1999-06-14 2000-06-13 A structured peptide scaffold for displaying turn libraries on phage IL146798A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13901799P 1999-06-14 1999-06-14
PCT/US2000/016368 WO2000077194A1 (en) 1999-06-14 2000-06-13 A structured peptide scaffold for displaying turn libraries on phage

Publications (1)

Publication Number Publication Date
IL146798A0 true IL146798A0 (en) 2002-07-25

Family

ID=22484754

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14679800A IL146798A0 (en) 1999-06-14 2000-06-13 A structured peptide scaffold for displaying turn libraries on phage

Country Status (10)

Country Link
US (2) US7235626B1 (ja)
EP (1) EP1187914B1 (ja)
JP (1) JP2003502304A (ja)
AT (1) ATE296350T1 (ja)
AU (1) AU782755C (ja)
CA (1) CA2376232A1 (ja)
DE (1) DE60020366T2 (ja)
ES (1) ES2242620T3 (ja)
IL (1) IL146798A0 (ja)
WO (1) WO2000077194A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1187914B1 (en) 1999-06-14 2005-05-25 Genentech, Inc. A structured peptide scaffold for displaying turn libraries on phage
DE10023743A1 (de) * 2000-05-15 2001-11-29 Max Planck Gesellschaft Peptidsubstrate zur direkten Messung enzymatischer Aktivitäten
US6914123B2 (en) 2001-04-17 2005-07-05 Genentech, Inc. Hairpin peptides with a novel structural motif and methods relating thereto
EP1513879B1 (en) 2002-06-03 2018-08-22 Genentech, Inc. Synthetic antibody phage libraries
WO2004020981A2 (en) * 2002-08-30 2004-03-11 Rigel Pharmaceuticals, Inc. Methods of screening cyclic peptides and identifying targets therefor
CA2510003A1 (en) * 2003-01-16 2004-08-05 Genentech, Inc. Synthetic antibody phage libraries
CN100595277C (zh) 2003-11-15 2010-03-24 波利弗尔有限公司 模板固定的β发夹环模拟物及其在噬菌体展示中的用途
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US8933197B2 (en) * 2007-08-15 2015-01-13 Amunix Operating Inc. Compositions comprising modified biologically active polypeptides
MX362028B (es) 2009-02-03 2019-01-04 Amunix Pharmaceuticals Inc Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos.
JPWO2011024887A1 (ja) * 2009-08-26 2013-01-31 国立大学法人 岡山大学 環状ペプチドを含む結合体およびその作製方法
JP5677454B2 (ja) * 2009-12-11 2015-02-25 グワンジュ・インスティテュート・オブ・サイエンス・アンド・テクノロジー 細胞内ターゲット結合用二座ペプチドバインダー
KR101341640B1 (ko) * 2010-02-05 2013-12-16 한국전자통신연구원 단백질 미세 구조 분석 방법 및 단백질 미세 구조 분석용 어레이
JP4955795B2 (ja) * 2010-05-14 2012-06-20 株式会社日本製鋼所 造粒方法及び造粒装置
CN107058285A (zh) 2010-08-13 2017-08-18 米蒂生物系统有限公司 修饰肽的展示
EP4122945A1 (en) 2013-12-23 2023-01-25 University of Rochester Methods and compositions for ribosomal synthesis of macrocyclic peptides
EP2940138B1 (en) 2014-04-30 2018-02-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Phage display library
EP3137482A1 (en) 2014-05-02 2017-03-08 MorphoSys AG Peptide libraries
WO2016023896A1 (en) * 2014-08-11 2016-02-18 Miti Biosystems GmbH Enzyme fused to a leader for cyclic peptide display
JP6810041B2 (ja) 2014-12-22 2021-01-06 ランティオペプ ベスローテン ヴェンノーツハップＬａｎｔｈｉｏＰｅｐ Ｂ．Ｖ． バクテリオファージ粒子上に環状ペプチドを提示する新規の方法
WO2021007436A1 (en) * 2019-07-09 2021-01-14 Tavotek Biotherapeutics (Hong Kong) Limited Tricyclic peptide as protein binders and modulators and uses thereof
US20210338833A1 (en) 2020-05-01 2021-11-04 Massachusetts Institute Of Technology Chimeric antigen receptor-targeting ligands and uses thereof
US20210340524A1 (en) 2020-05-01 2021-11-04 Massachusetts Institute Of Technology Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
WO2023146791A1 (en) * 2022-01-27 2023-08-03 Academia Sinica Peptide-mediated delivery of active agents

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215865A (en) 1985-04-22 1988-10-28 Commw Serum Lab Commission Method of determining the active site of a receptor-binding analogue
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
DK0564531T3 (da) 1990-12-03 1998-09-28 Genentech Inc Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
US5885780A (en) 1991-07-19 1999-03-23 University Of Utah Method of obtaining small conformationally rigid conopeptides
EP0656907A1 (en) 1992-08-06 1995-06-14 Molecumetics, Ltd. Conformationally restricted mimetics of reverse turns and peptides containing the same
EP0788370A4 (en) 1993-07-09 1998-07-08 Smithkline Beecham Corp CYCLIC, PARTIAL RANDOM PEPTIDE LIBRARIES
US5830851A (en) 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5824483A (en) 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
EP0760012A4 (en) 1994-06-10 1997-07-02 Symbiotech Inc METHODS FOR DETECTING COMPOUNDS BY MEANS OF GENETICALLY MODIFIED LAMBDA BACTERIOPHAGE
US6100377A (en) 1994-06-10 2000-08-08 The Trustees Of The University Of Pennsylvania Constrained peptides
US5627024A (en) 1994-08-05 1997-05-06 The Scripps Research Institute Lambdoid bacteriophage vectors for expression and display of foreign proteins
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6475806B1 (en) 1995-06-07 2002-11-05 Praecis Pharmaceuticals, Inc. Anchor libraries and identification of peptide binding sequences
US6013458A (en) 1995-10-27 2000-01-11 Molecumetics, Ltd. Reverse-turn mimetics and methods relating thereto
SE506771C2 (sv) 1996-02-06 1998-02-09 Gotpat 105 Ab Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna
US5866341A (en) 1996-04-03 1999-02-02 Chugai Pharmaceutical Co., Ltd. Compositions and methods for screening drug libraries
US5766905A (en) 1996-06-14 1998-06-16 Associated Universities Inc. Cytoplasmic bacteriophage display system
WO1999051625A2 (en) 1998-04-02 1999-10-14 Rigel Pharmaceuticals, Inc. Peptides causing formation of compact structures
US6180343B1 (en) 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides
EP1187914B1 (en) 1999-06-14 2005-05-25 Genentech, Inc. A structured peptide scaffold for displaying turn libraries on phage
CN1318084C (zh) 2000-05-26 2007-05-30 奥索-麦克尼尔药品公司 神经保护肽

Also Published As

Publication number Publication date
EP1187914A1 (en) 2002-03-20
ATE296350T1 (de) 2005-06-15
AU782755C (en) 2006-04-27
EP1187914B1 (en) 2005-05-25
DE60020366D1 (de) 2005-06-30
WO2000077194A1 (en) 2000-12-21
DE60020366T2 (de) 2006-02-02
US7235626B1 (en) 2007-06-26
AU5611900A (en) 2001-01-02
ES2242620T3 (es) 2005-11-16
AU782755B2 (en) 2005-08-25
JP2003502304A (ja) 2003-01-21
CA2376232A1 (en) 2000-12-21
US20060110777A1 (en) 2006-05-25

Similar Documents

Publication Publication Date Title
IL146798A0 (en) A structured peptide scaffold for displaying turn libraries on phage
Melendez et al. Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-Aza1-dipeptides in peptide synthesis
Jwad et al. Strategies for fine-tuning the conformations of cyclic peptides
Choi et al. Recent trends in cyclic peptides as therapeutic agents and biochemical tools
Souers et al. β-Turn mimetic library synthesis: scaffolds and applications
JP4310106B2 (ja) 抗菌活性を有するテンプレート結合ペプチド擬似体
Brouwer et al. Peptido sulfonyl fluorides as new powerful proteasome inhibitors
WO2004035735A3 (en) A structured peptide scaffold for displaying turn libraries on phage
Spatola et al. Rediscovering an endothelin antagonist (BQ-123): A self-deconvoluting cyclic pentapeptide library
CA2466591C (en) Template-fixed peptidomimetics as inhibitors of serine proteases
Wittmann et al. Combinatorial Solid‐Phase Synthesis of Multivalent Cyclic Neoglycopeptides
Slomczynska et al. Electrochemical cyclization of dipeptides to form novel bicyclic, reverse-turn peptidomimetics. 2. Synthesis and conformational analysis of 6, 5-bicyclic systems
Wessjohann et al. Applications of convertible isonitriles in the ligation and macrocyclization of multicomponent reaction-derived peptides and depsipeptides
Lee et al. Oligomers of N-substituted β2-homoalanines: Peptoids with backbone chirality
Panda et al. Traceless chemical ligation from S-, O-, and N-acyl isopeptides
Turner et al. Selective, on-resin N-methylation of peptide N-trifluoroacetamides
Park et al. Facile solid-phase parallel synthesis of linear and cyclic peptoids for comparative studies of biological activity
JP2006513981A (ja) 抗菌活性を有するテンプレート結合ペプチド擬似体
Rosenström et al. Design, synthesis, and incorporation of a β-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors
Lucke et al. Designing supramolecular structures from models of cyclic peptide scaffolds with heterocyclic constraints
Ramanathan et al. Modular synthesis of cyclic peptidomimetics inspired by γ-turns
Bélec et al. A study of the relationship between biological activity and prolyl amide isomer geometry in oxytocin using 5-tert-butylproline to augment the Cys6-Pro7 amide cis-isomer population
Marciano et al. N-Acetylation of Biodegradable Supramolecular Peptide Nanofilaments Selectively Enhances Their Proteolytic Stability for Targeted Delivery of Gold-Based Anticancer Agents
De Marco et al. In-Peptide synthesis of imidazolidin-2-one scaffolds, equippable with proteinogenic or taggable/linkable side chains, general promoters of unusual secondary structures
Wang et al. Highly Sterically Hindered Peptide Bond Formation between α, α-Disubstituted α-Amino Acids and N-Alkyl Cysteines Using α, α-Disubstituted α-Amidonitrile